Epidemiology and differential diagnosis of nasal polyps

American Journal of Rhinology and Allergy

Volumn 27, Issue 6, 2013, Pages 473-478

  Chaaban, Mohamad R ^a   Walsh, Erika M ^a   Woodworth, Bradford A ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

ALLERGIC FUNGAL RHINOSINUSITIS; APOPTOSIS; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; BRONCHOCONSTRICTION; CELL HYPERPLASIA; CHRONIC RHINOSINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; EDEMA; ENDOSCOPIC SINUS SURGERY; EOSINOPHILIC CHRONIC RHINOSINUSITIS; EOSINOPHILIC FUNGAL RHINOSINUSITIS; EOSINOPHILIC MUCIN RHINOSINUSITIS; EPIDEMIOLOGY; HUMAN; INFLAMMATION; NOSE POLYP; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POLYPOSIS; PREVALENCE; REVIEW; RHINOSINUSITIS;

ASPIRIN; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 84890948173     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3981     Document Type: Review

References (99)

1. Kern RC, Conley DB, Walsh W, et al. Perspectives on the etiology of chronic rhinosinusitis: An immune barrier hypothesis. Am J Rhinol 22:549-559, 2008.
2. Lanza DC, and Kennedy DW. Adult rhinosinusitis defined. Otolaryngol Head Neck Surg 117:S1-S7, 1997.
3. Rosenfeld R. Clinical practice guideline on adult sinusitis. Otolaryngol Head Neck Surg 137:365-377, 2007.
4. Fokkens WJ, Lund VJ, Mullol J, et al. EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology 50:1-12.
5. Fokkens WJ, Lund VJ, Mullol J, et al. European position paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl 23:1-298, 2012.
6. Alobid I, Cardelus S, Benitez P, et al. Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. Rhinology 49:519-524, 2011.
7. Alobid I, Benitez P, Bernal-Sprekelsen M, et al. The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis. Qual Life Res 14:789-793, 2005.
8. Guilemany JM, Angrill J, Alobid I, et al. United airways: The impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient's quality of life. Allergy 64:1524-1529, 2009.
9. Collins JG. Prevalence of selected chronic conditions: United States, 1990-1992. Vital Health Stat 10 194:1-89, 1997.
10. Pleis JR, Lucas JW, and Ward BW. Summary health statistics for U.S. adults: National Health Interview Survey, 2008. Vital Health Stat 10 242:1-157, 2009.
11. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe. Allergy 67:91-98, 2012.
12. Shashy RG, Moore EJ, and Weaver A. Prevalence of the chronic sinusitis diagnosis in Olmsted County, Minnesota. Arch Otolaryngol Head Neck Surg 130:320-323, 2004.
13. Johansson L, Akerlund A, Holmberg K, et al. Prevalence of nasal polyps in adults: The Skövdepopulation-based study. Ann Otol Rhinol Laryngol 112:625-629, 2003.
14. Chen Y, Dales R, and Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 113:1199-1205, 2003.
15. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61:1280-1289, 2006.
16. Jiang XD, Li GY, Li L, et al. The characterization of IL-17A expression in patients with chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy 25:e171-e175, 2011.
17. Hedman J, Kaprio J, Poussa T, and Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 28:717-722, 1999.
18. Hosemann W, Gode U, and Wagner W. Epidemiology, pathophysiology of nasal polyposis, and spectrum of endonasal sinus surgery. Am J Otolaryngol 15:85-98, 1994.
19. Larsen K, and Tos M. The estimated incidence of symptomatic nasal polyps. Acta Otolaryngol 122:179-182, 2002.
20. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: Definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 129(suppl):S1-S32, 2003.
21. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol 122:961-968, 2008.
22. Wen W, Liu W, Zhang L, et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy. J Allergy Clin Immunol 129:1522-1528, 2012.
23. Kim JW, Hong SL, Kim YK, et al. Histological and immunological features of non-eosinophilic nasal polyps. Otolaryngol Head Neck Surg 137:925-930, 2007.
24. Jareonchasri P, Bunnag C, Muangsomboon S, et al. Clinical and histopathological classification of nasal polyps in Thias. Siriraj Hosp Gaz 54:689-697, 2002.
25. Ragab A, Clement P, and Vincken W. Objective assessment of lower airway involvement in chronic rhinosinusitis. Am J Rhinol 18:15-21, 2004.
26. Bachert C, Zhang N, Holtappels G, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol 126:962-968, 2010.
27. Chanez P, Vignola AM, Vic P, et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 159:588-595, 1999.
28. Mattos JL, Woodard CR, and Payne SC. Trends in common rhinologic illnesses: Analysis of U.S. healthcare surveys 1995-2007. Int Forum Allergy Rhinol 1:3-12, 2011.
29. Ferguson BJ. Eosinophilic mucin rhinosinusitis: A distinct clinicopathological entity. Laryngoscope 110:799-813, 2000.
30. Saravanan K, Panda NK, Chakrabarti A, et al. Allergic fungal rhinosinusitis: An attempt to resolve the diagnostic dilemma. Arch Otolaryngol Head Neck Surg 132:173-178, 2006.
31. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: An enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 114:1369-1375, 2004.
32. Taylor MJ, Ponikau JU, Sherris DA, et al. Detection of fungal organisms in eosinophilic mucin using a fluorescein-labeled chitin-specific binding protein. Otolaryngol Head Neck Surg 127:377-383, 2002.
33. Kim ST, Choi JH, Jeon HG, et al. Comparison between polymerase chain reaction and fungal culture for the detection of fungi in patients with chronic sinusitis and normal controls. Acta Otolaryngol 125:72-75, 2005.
34. Polzehl D, Weschta M, Podbielski A, et al. Fungus culture and PCR in nasal lavage samples of patients with chronic rhinosinusitis. J Med Microbiol 54:31-37, 2005.
35. Rao AK, Mathers PH, and Ramadan HH. Detection of fungi in the sinus mucosa using polymerase chain reaction. Otolaryngol Head Neck Surg 134:581-585, 2006.
36. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 74:877-884, 1999.
37. Panikau JU, Sherris DA, Kephart GM, et al. Striking deposition of toxic eosinophil major protein in mucus: Implications for chronic rhinosinusitis. J Allergy Clin Immunol 116:362-369, 2005.
38. Bachert C, Gevaert P, Holtappels G, et al. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107:607-614, 2001.
39. Gevaert P, Holtappels G, Johansson SG, et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue. Allergy 60:71-79, 2005.
40. Sabirov A, Hamilton RG, Jacobs JB, et al. Role of local immunoglobulin E specific for Alternaria alternata in the pathogenesis of nasal polyposis. Laryngoscope 118:4-9, 2008.
41. Shin SY, Ye YM, Eun YG, et al. Local IgE-mediated hypersensitivity to Alternaria in pediatric adenoid tissue. Int J Pediatr Otorhinolaryngol 76:1423-1428, 2001.
42. Marple BF. Allergic fungal rhinosinusitis: Current theories and management strategies. Laryngoscope 111:1006-1019, 2001.
43. Horst M, Hejjaoui A, Horst V, et al. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol 85:460-472, 1990.
44. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different NOT MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 106:723-729, 2000.
45. Bent JP III, and Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 111:580-588, 1994.
46. Manning SC, Vuitch F, Weinberg AG, and Brown OE. Allergic aspergillosis: A newly recognized form of sinusitis in the pediatric population. Laryngoscope 99:681-685, 1989.
47. Schubert MS, and Goetz DW. Evaluation and treatment of allergic fungal sinusitis. I. Demographics and diagnosis. J Allergy Clin Immunol 102:387-394, 1998.
48. Schubert MS, and Goetz DW. Evaluation and treatment of allergic fungal sinusitis. II. Treatment and follow-up. J Allergy Clin Immunol 102:395-402, 1998.
49. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114(suppl):155-212, 2004.
50. Manning SC and Holman M. Further evidence for allergic pathophysiology in allergic fungal sinusitis. Laryngoscope 108:1485-1496, 1998.
51. Clark DW, Wenaas A, Luong A, et al. Staphylococcus aureus prevalence in allergic fungal rhinosinusitis vs other subsets of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol 3:89-93, 2013.
52. Hutcheson PS, Oliver DA, Schubert MS, and Slavin RG. The association of total IgE and specific IgE anti-staphylococcal enterotoxin with chronic hyperplastic rhinosinusitis. J Allergy Clin Immunol 117:S71, 2006. (Ab 278).
53. Ferguson BJ, Seethala R, and Wood WA. Eosinophilic bacterial chronic rhinosinusitis. Laryngoscope 117:2036-2040, 2007.
54. Schubert MS. A superantigen hypothesis for the pathogenesis of chronic hypertrophic rhinosinusitis, allergic fungal sinusitis, and related disorders. Ann Allergy Asthma Immunol 87:181-188, 2001.
55. Widal F, Abrami P, and Lermoyez J. Anaphylaxie et idiosyncrasie. 1992 [Anaphylaxis and idiosyncrasy. 1992]. Allergy Proc 14:373-376, 1993.
56. Samter M, and Beers RF Jr. Concerning the nature of intolerance to aspirin. J Allergy 40:281-293, 1967.
57. Berges-Gimeno MP, Simon RA, and Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 89:474-478, 2002.
58. Jenkins C, Costello J, and Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ 328:434, 2004.
59. Stevenson DD, Sanchez-Borges M, and Szczeklik A. Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol 87:177-180, 2001.
60. Stevenson DD. Aspirin desensitization in patients with AERD. Clin Rev Allergy Immunol 24:159-168, 2003.
61. Bavbek S, Dursun B, Dursun E, et al. The prevalence of aspirin hypersensitivity in patients with nasal polyposis and contributing factors. Am J Rhinol Allergy 25:411-415, 2011.
62. Kowalski ML, Grzegorczyk J, Pawliczak R, et al. Decreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivity. Allergy 57:493-500, 2002.
63. Szczeklik A. Aspirin-induced asthma as a viral disease. Clin Allergy 18:15-20, 1988.
64. Davoine F, Cao M, Wu Y, et al. Virus-induced eosinophil mediator release requires antigen-presenting and CD4+ T cells. J Allergy Clin Immunol 122:69-77, 2008.
65. Douglas GC, Karkos PD, and Swift AC. Aspirin sensitivity and the nose. Br J Hosp Med (Lond) 71:442-445, 2010.
66. Kowalski ML. Rhinosinusitis and nasal polyposis in aspirin sensitive and aspirin tolerant patients: Are they different? Thorax 55(suppl 2):S84-S86, 2000.
67. Picado C. Aspirin intolerance and nasal polyposis. Curr Allergy Asthma Rep 2:488-493, 2002.
68. Palikhe NS, Kim JH, and Park HS. Update on recent advances in the management of aspirin exacerbated respiratory disease. Yonsei Med J 50:744-750, 2009.
69. Szczeklik A, Nizankowska E, and Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J 16:432-436, 2000.
70. Szczeklik A, and Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 111:913-921, 2003.
71. Bachert C, Gevaert P, and van Cauwenberge P. Nasal polyposis - A new concept on the formation of polyps. Allergy Clin Immunol Int. 11:130-135, 1999.
72. Fruth K, Schramek E, Docter D, et al. Dysregulated survivin expression in nasal polyps of individuals with aspirin exacerbated respiratory disease. Am J Rhinol Allergy 26:380-384, 2012.
73. Delaney JC. The diagnosis of aspirin idiosyncrasy by analgesic challenge. Clin Allergy 6:177-181, 1976.
74. Stevenson DD, and Zuraw BL. Pathogenesis of aspirin-exacerbated respiratory disease. Clin Rev Allergy Immunol 24:169-188, 2003.
75. Hope AP, Woessner KA, Simon RA, and Stevenson DD. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 123:406-410, 2009.
76. Baenkler HW. Salicylate intolerance: Pathophysiology, clinical spectrum, diagnosis and treatment. Dtsch Arztebl Int 105:137-142, 2008.
77. Rowe SM, Miller S, and Sorscher EJ. Cystic fibrosis. N Engl J Med 352:1992-2001, 2005.
78. Riordan JR, Rommens JM, Kerem B, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073, 1989.
79. Rosenstein BJ, and Cutting GR. The diagnosis of cystic fibrosis: A consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132:589-595, 1998.
80. Tandon R, and Derkay C. Contemporary management of rhinosinusitis and cystic fibrosis. Curr Opin Otolaryngol Head Neck Surg 11:41-44, 2003.
81. Ryan MW. Diseases associated with chronic rhinosinusitis: What is the significance? Curr Opin Otolaryngol Head Neck Surg 16:231-236, 2008.
82. Gentile VG, and Isaacson G. Patterns of sinusitis in cystic fibrosis. Laryngoscope 106:1005-1009, 1996.
83. Shapiro ED, Milmoe GJ, Wald ER, et al. Bacteriology of the maxillary sinuses in patients with cystic fibrosis. J Infect Dis 146:589-593, 1982.
84. Hui Y, Gaffney R, and Crysdale WS. Sinusitis in patients with cystic fibrosis. Eur Arch Otorhinolaryngol 252:191-196, 1995.
85. Ledesma-Medina J, Osman MZ, and Girdany BR. Abnormal paranasal sinuses in patients with cystic fibrosis of the pancreas. Radiological findings. Pediatr Radiol 9:61-64, 1980.
86. Neely JG, Harrison GM, Jerger JF, et al. The otolaryngologic aspects of cystic fibrosis. Trans Am Acad Ophthalmol Otolaryngol 76:313-324, 1972.
87. Woodworth BA, Ahn C, Flume PA, and Schlosser RJ. The delta F508 mutation in cystic fibrosis and impact on sinus development. Am J Rhinol 21:122-127, 2007.
88. Seifert CM, Harvey RJ, Mathews JW, et al. Temporal bone pneumatization and its relationship to paranasal sinus development in cystic fibrosis. Rhinology 48:233-238, 2010.
89. Guttenplan MD, and Wetmore RF. Paranasal sinus mucocele in cystic fibrosis. Clin Pediatr (Phila) 28:429-430, 1989.
90. Tunkel DE, Naclerio RM, Baroody FM, and Rosenstein BJ. Bilateral maxillary sinus mucoceles in an infant with cystic fibrosis. Otolaryngol Head Neck Surg 111:116-120, 1994.
91. Raman V, Clary R, Siegrist KL, et al. Increased prevalence of mutations in the cystic fibrosis transmembrane conductance regulator in children with chronic rhinosinusitis. Pediatrics 109:E13, 2002.
92. Cohen NA, Zhang S, Sharp DB, et al. Cigarette smoke condensate inhibits transepithelial chloride transport and ciliary beat frequency. Laryngoscope 6:177-181, 1976.
93. Virgin FW, Azbell C, Schuster D, et al. Exposure to cigarette smoke condensate reduces calcium activated chloride channel transport in primary sinonasal epithelial cultures. Laryngoscope 120:1465-1469, 2010.
94. Blount A, Zhang S, Chestnut M, et al. Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium. Laryngoscope 121:1929-1934, 2011.
95. Alexander NS, Blount A, Zhang S, et al. Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein. Laryngoscope 122:1193-1197, 2012.
96. Azbell C, Zhang S, Skinner D, et al. Hesperidin stimulates cystic fibrosis transmembrane conductance regulator-mediated chloride secretion and ciliary beat frequency in sinonasal epithelium. Otolaryngol Head Neck Surg 143:397-404, 2010.
97. Virgin F, Zhang S, Schuster D, et al. The bioflavonoid compound, sinupret, stimulates transepithelial chloride transport in vitro and in vivo. Laryngoscope 120:1051-1056, 2010.
98. Alexander NS, Hatch N, Zhang S, et al. Resveratrol has salutary effects on mucociliary transport and inflammation in sinonasal epithelium. Laryngoscope 121:1313-1319, 2011.
99. Zhang S, Smith N, Schuster D, et al. Quercetin increases cystic fibrosis transmembrane conductance regulator-mediated chloride transport and ciliary beat frequency: Therapeutic implications for chronic rhinosinusitis. Am J Rhinol Allergy 25:307-312, 2011.